Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Talzenna (talazoparib) for the Treatment of Advanced Breast Cancer

Drug Name

Talzenna™ (talazoparib)

Developer

Pfizer

Therapy Class

Enzyme inhibitor

Product Description

Poly ADP-ribose polymerase inhibitor

Current Indication

Advanced or metastatic breast cancer

Market Sector

Oncology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top